<DOC>
	<DOCNO>NCT02428868</DOCNO>
	<brief_summary>It prospective randomize control study aim test tranexamic acid combine intravenous iron surgery hip fracture elderly decrease peri-operative red cell transfusion .</brief_summary>
	<brief_title>IV Iron Association With Tranexamic Acid Hip Fracture</brief_title>
	<detailed_description>Hip fracture increase problem . Anemia common finding patient prevalence range 24 % 44 % strong negative prognostic marker . Several study explore whether intervention improve anemia result well outcome . Thus , alternative allogenic red cell transfusion suggest hip fracture , IV iron tranexamic acid . The aim study test effect combination IV iron tranexamic acid surgery hip fracture incidence peri-operative red cell transfusion . It prospective randomize single-blinded monocentric study include 150 patient undergoing hip fracture surgery within 72 h trauma age â‰¥ 60 year divide 3 group : Group A ( IV fer+Tranexamic acid ) , Group B ( Tranexamic acid ) , Group C ( placebo ) . The main outcome percentage patient receive red-cell transfusion hospitalization . Hemoglobin level 60 day post-operatively incidence thrombotic event secondary outcome .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients undergo hip fracture surgery within 72 h trauma . Vascular event within last 2 month cerebrovascular accident ( CVA ) , Myocardial infarction ( MI ) , Venous Thromboembolism ( VTE ) and/or recurrent VTE arterial thrombosis . Patients receive anticoagulation therapy warfarin clopidogrel . History seizure . Multiple fracture . Transfusion receive admission , prior surgery ( Hb &lt; 8g/dl ) . Creatinine clearance le 30 mL/min Known history Factor V Leiden , protein C/S deficiency , prothrombin gene mutation , antithrombin deficiency , antiphospholipid antibody syndrome , lupus anticoagulant Coronary stent placement within previous 6 month Disseminated intravascular coagulation Subarachnoid hemorrhage Allergy tranexamic acid Hypersensitivity Iron sucrose component formulation Clinical sign acute thromboembolic event Malignancy Body weight &gt; 100kg Advanced Dementia</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>hip fracture</keyword>
	<keyword>anemia</keyword>
	<keyword>blood transfusion</keyword>
	<keyword>tranexamic acid</keyword>
	<keyword>intravenous iron</keyword>
</DOC>